Learn more about whether Corcept Therapeutics Incorporated or Haleon plc is a better investment based on AAII's A+ Investor ...
Sei Investments Co. cut its stake in shares of Haleon plc (NYSE:HLN – Free Report) by 1.6% during the 4th quarter, Holdings ...
Haleon PLC closed 6.66% short of its 52-week high of £4.18, which the company reached on March 4th.
Commonwealth Equity Services LLC lessened its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 3.3% in the fourth ...
GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...
Haleon offers plenty of stability amidst the current market volatility, with its Power Brands driving strong organic growth.
Haleon PLC HLN shares slid 1.91% to £3.86 Monday, on what proved to be an all-around poor trading session for the stock ...
Haleon has named Nathalie Gerschtein as president North America, following Lisa Paley’s announcement to step down from her ...
In a report released on March 20, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price ...
Gerschtein is pivoting to the consumer health space after nearly 23 years in beauty at L'Oréal serving a variety of brands ...
11d
Zacks Investment Research on MSNPharma Stock Roundup: PFE's Final Haleon Stake Sale, AZN, SNY M&A DealsThis week, the FDA approved J&J’s JNJ Tremfya for its second inflammatory bowel disease (“IBD”) condition, Crohn’s disease ...
Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results